This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This brings the pass rates back down almost to November 2022 levels of 56%, following a 10% rise to 66% in November 2023. And it comes as summer pass rates have seen a steady decline […] The post GPhC November pass rate drops again to 2022 levels appeared first on The Pharmacist.
Last Words Substance use disorders (SUD) are similar to other chronic relapsing medical conditions such as diabetes mellitus, congestive heart failure/cardiomyopathy, chronic obstructive pulmonary disorder, and cancer. Drug Checking Quarterly Report (Q3 2022). 2022; 06/26/2023. 2022 May;14(5). 2011 Dec;6:1-4.
Health tech investments are showing signs of resilience following the perilous lows of 2022 and 2023: Just this past month, two startups that analysts believe might be getting ready for IPOs raised more than $100 million in late-stage funding rounds.
Products in this category are often prescribed by practitioners, such as nephrologists for renal care or diabetologists for managing diabetes. billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3 billion in 2023 and is expected to grow at a CAGR of 8.4 per cent from 2024 to 2030.
The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9 per cent from $2.2
Image Credit: Elena | stock.adobe.com A 2022 study reported that approximately 90% of the United States population lives within 5 miles of a pharmacy. Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates.
November 7, 2022. American Pharmacists Association. Accessed May 29, 2025. link] Disparities in flu vaccination coverage are cause for concern. National Foundation for Infectious Diseases. Accessed May 29, 2025.
Study Overview Researchers conducted a retrospective chart review of 80 patients aged 12 or older within Intermountain Health who were diagnosed with asthma between December 2022 and December 2023. To ensure continuity of care, patients included had seen a primary care provider both in the year prior to and following their diagnosis.
December 2022. News release. Oregon Health and Science University. May 9, 2019. Accessed July 11, 2025. Arkansas Maternal Mortality Review Committee. Legislative Report. Accessed July 11, 2025. Koonin LM, Patel A. Timely antiviral administration during an influenza pandemic: key components. Am J Public Health. 2018;108(Suppl 3):S215-S220.
Its average fiscal year 2022 readmission rate was 23.7%, exceeding the 19.6% The hospital-approved protocol, created in June 2022, granted TOC pharmacists prescribing authority for guideline-directed medical therapy (GDMT), consisting of a 30-day supply of rescue and triple-therapy inhalers, at discharge for patients with AECOPD.
May 4, 2022. Isatuximab shows promise in enhancing PFS for patients with multiple myeloma. Pharmacy Times. August 8, 2024. Accessed July 8, 2025. Multiple myeloma. Cleveland Clinic. Accessed July 8, 2025.
The trial was conducted from January 2021 to December 2022, with a feedback letter sent on or after January 2022, including physicians that were randomly assigned in a 4 to 1 allocation. The misuse and overuse of antimicrobials to treat, prevent, and control infections has influenced the spread of AMR.
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk’s diabetes drug, liraglutide, to its platform in 2025. It results in less weight loss on average than Novo’s newer in-demand Wegovy, which launched in 2020 and was approved in 2022 for adolescents aged 12 and older.
For example, long-acting formulations, less painful injection methods, and fixed-dose combination therapies have each played a critical role in improving adherence and outcomes in conditions such as diabetes, autoimmune diseases, and HIV. 15 Inflation Reduction Act of 2022 , Pub. 1818 (2022). 6 (June 2022): e2215227.
In 2022, CMS reevaluated 505(b)(2) drugs in relation to section 1847A of the Social Security Act (SSA). In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. This went into effect in January 2022.”
Updated September 21, 2022. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9. doi:10.1002/acr.24495. Gonococcal Infections Among Adolescents and Adults. Centers for Disease Control and Prevention. Accessed March 5, 2025.
link] 2022 global strategy for prevention, diagnosis, and management of COPD. Updated 2022. Lancet Respir Med.2022;10(5):447-458. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7 Global strategy for asthma management and prevention. Accessed June 6,2025. Global Initiative for Asthma. Accessed June 6, 2025. Subscribe Now!
September 28, 2022. trillion economic impact in 2020. In this study, participants experienced maximum concentration level reductions of up to 30% when exposed to higher buffer ingredient levels. It just might start saving lives. REFERENCES 1. The economic toll of the opioid crisis reached nearly $1.5 trillion in 2020. Accessed May 27, 2025.
1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).
According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0% Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Despite their purported efficacy and safety, uptake remains below target levels. Last Updated October 26, 2024. Accessed July 23, 2025.
For example, CPAs are especially impactful in managing chronic conditions such as diabetes, heart failure, and rheumatoid arthritis, where pharmacist intervention has been shown to improve outcomes and reduce hospitalizations. Creating disease-specific competency assessments also ensures alignment with evolving standards of care.
4 Nononcology applications are growing, however, particularly for conditions such as osteoarthritis, type 1 diabetes, and Parkinson disease. CD19-directed CAR T therapy has shown promising outcomes in systemic lupus erythematosus, prompting more than a dozen trials targeting lupus, type 1 diabetes, myasthenia gravis, and multiple sclerosis.
Patients were enrolled from 31 sites across 4 countries between December 5, 2022, and September 19, 2023. Adalimumab received its initial approval from the FDA for the treatment of rheumatoid arthritis. 3 The trial’s primary objective was to evaluate the interchangeability of low-concentration Hulio (40 mg/0.8
It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans. The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target.
OTC Use Saves Billions From Cost-Effective Products and Encounters Image credit: Amina | stock.adobe.com A 2022 publication purported $167 billion in savings in ancillary health care cost avoidance through the widespread use of OTC products in the United States. November 2022. REFERENCES The power of OTCs to provide consumer value.
Updated October 6, 2022. Anemia (grade 1–2: n = 15, 21.1%; grade 3–4: n = 6, 8.5%), neutropenia (grade 1–2: n = 15, 21.1%; grade 3–4: n = 4, 5.6%) and thrombocytopenia (grade 1–2: n = 8, 11.2%; grade 3–4: n = 3, 4.2%) were the most common hematologic AEs. Continued study is needed to further elucidate the results of the study. REFERENCES 1.
November 16, 2022. Accessed June 12, 2025. Deng S, Meng F, Wang L, et al. Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis. Front Oncol. doi:10.3389/fonc.2022.1044830 2022.1044830 3. Prasad SM, Shishkov D, Mihaylov NV, et al.
diabetes mellitus , hypothyroidism, depression , eating disorders, pregnancy, multiple sclerosis, etc.) Lactulose and Diabetes Different form lactose, lactulose is a manmade sugar that is broken down in the bowel so very little gets into the bloodstream. Hence, it may be used short term in diabetic patients.
Press Release, March 2, 2022. FDA Approves Roche’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-related Blindness. Challener News Article Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise. link] Cleveland Clinic. Punctal Plugs. link] Charters, L.
North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. July 1, 2024. Accessed June 6, 2025. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025.
Reviewing Medication Adherence According to the WeAllCount Census for 2022 to 2023, 6 homelessness in San Diego increased by 22% (from 8427 to 10,264 individuals). Subscribe Now!
In 2022, it received approval from the FDA for patients with HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) infection. December 22, 2022. 10,11 REFERENCES 1. Gilead Sciences. News Release. Accessed June 6, 2025.
Only 4% of global drugs sales will have patent protection, compared to 12% and 6% in 2022 and 2024. According to a Reuters article, pharma companies launched new US drugs at prices 35% higher in 2023, compared to those launched in 2022. Biosimilars and generics can be as much as 80% cheaper than branded alternatives.
Biden’s 2022 Inflation Reduction Act (IRA), creating an out-of-pocket spending cap of $2000 starting in 2025, and Part D has become a very generous pharmacy benefit. A 2024 RAND study using 2022 data found that among Organisation for Economic Co-operation and Development (OECD) countries (comparably developed nations), the US paid 4.22
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content